RNA5SP66

Across TCGA pan-cancer cohorts, RNA5SP66 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNA5SP66 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNA5SP66 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP66 expression acts as an unfavorable survival marker.

READ, UCEC, and COAD are the cancer types where RNA5SP66 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	117	view →
UCEC	OS	Tertile	II,III,IV	0.198	0.768	.002	72	view →
COAD	OS	Tertile	IV	0.045	0.659	<.001	36	view →
BRCA	DFS	Tertile	All	0.873	0.951	.038	24	view →
LUAD	OS	Tertile	All	0.655	0.841	.007	24	view →
STAD	OS	Tertile	III,IV	0.224	0.640	.021	18	view →
LAML	DFS	Tertile	All	0.140	0.582	.020	18	view →
LGG	DFS	Tertile	All	0.110	0.826	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNA5SP66–READ (OS)

Open the READ breakdown →